173 related articles for article (PubMed ID: 10378785)
1. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.
Iizuka N; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Oka M
Cancer Lett; 1999 Apr; 138(1-2):139-44. PubMed ID: 10378785
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
3. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
4. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
5. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
7. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Eur J Cardiothorac Surg; 2001 Jun; 19(6):904-7. PubMed ID: 11404150
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
10. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
Zhou Y; Xu A; Ling X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
[TBL] [Abstract][Full Text] [Related]
11. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
12. The NM23 gene and its expression in oral squamous cell carcinoma.
Lo Muzio L; Mignogna MD; Pannone G; Staibano S; Procaccini M; Serpico R; De Rosa G; Scully C
Oncol Rep; 1999; 6(4):747-51. PubMed ID: 10373649
[TBL] [Abstract][Full Text] [Related]
13. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
Zhang T; Lai Q; Du D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
[TBL] [Abstract][Full Text] [Related]
14. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of nm23 in advanced esophageal squamous cell carcinoma.
Szumiło J; Skomra D; Chibowski D; Dabrowski A; Wallner G; Maciejewski R
Folia Histochem Cytobiol; 2002; 40(4):377-80. PubMed ID: 12502190
[TBL] [Abstract][Full Text] [Related]
16. [Study on expression of nm23-H1 protein/NDPK-A in laryngeal carcinoma].
Li J; Jin K; Yin S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):247-50. PubMed ID: 11189167
[TBL] [Abstract][Full Text] [Related]
17. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
18. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
20. The expression and clinical significance of metastasis suppressor gene and matrix metalloproteinase-2 in esophageal squamous cell of carcinoma.
Guo XQ; Li XY
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1339-42. PubMed ID: 27592483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
